For Healthcare Professionals Only.

Course modules

COURSE CHAIRMAN
Prof. dr. Gisela Terwindt is consultant neurologist and director of the Leiden Headache Center (LUMC, NL). She is chair of the scientific and headache guideline committee of the Dutch Headache Society and chair of the IHS Clinical Trial Guideline Committee and Female Leadership’s Forum, and participated as a committee member for the Classification of Headache Disorders (ICHD-3). Her research focuses on neurobiological and molecular triggering mechanisms that lead up to migraine attacks to identify treatment targets for prevention of attacks and disease progression. Her group is also studying pathogenesis of monogenic disorders such as Hemiplegic Migraine and Cerebral Hereditary Angiopathies, which serve as models for migraine pathogenesis and help improve insight into pathophysiology of common neurovascular disorders including stroke and vascular dementia. Terwindt is involved in exploring the migraine–stroke relationship, with a special focus on female-specific triggers for migraine and stroke. She has published ≈400 scientific papers, and received a prestigious personal grant from the Dutch Research Council. Terwindt received her MSc in Biology and MD in Medicine at the University of Leiden, Netherlands. Her PhD centred on epidemiology and genetics of migraine, and resulted in the discovery of the first migraine gene. See also www.hoofdpijnonderzoek.nl ; www.whatstudy.nl; www.RVCLS.com

Prof. Gisela Terwindt

Prof. dr. Gisela Terwindt is consultant neurologist and director of the Leiden Headache Center (LUMC, NL). She is chair of...
Welcome and a brief intro about the modules, ending with whishes for success in the course.

1 MODULE

Acute And Preventive Treatment Of Migraine
Professor and Vice Chair of Neurology at Albert Einstein College of Medicine in Bronx, New York
Read More
Prof. dr. Gisela Terwindt is consultant neurologist and director of the Leiden Headache Center (LUMC, NL). She is chair of the scientific and headache guideline committee of the Dutch Headache Society and chair of the IHS Clinical Trial Guideline Committee and Female Leadership’s Forum, and participated as a committee member for the Classification of Headache Disorders (ICHD-3). Her research focuses on neurobiological and molecular triggering mechanisms that lead up to migraine attacks to identify treatment targets for prevention of attacks and disease progression. Her group is also studying pathogenesis of monogenic disorders such as Hemiplegic Migraine and Cerebral Hereditary Angiopathies, which serve as models for migraine pathogenesis and help improve insight into pathophysiology of common neurovascular disorders including stroke and vascular dementia. Terwindt is involved in exploring the migraine–stroke relationship, with a special focus on female-specific triggers for migraine and stroke. She has published ≈400 scientific papers, and received a prestigious personal grant from the Dutch Research Council. Terwindt received her MSc in Biology and MD in Medicine at the University of Leiden, Netherlands. Her PhD centred on epidemiology and genetics of migraine, and resulted in the discovery of the first migraine gene. See also www.hoofdpijnonderzoek.nl ; www.whatstudy.nl; www.RVCLS.com
34:18Duration
Start module

2 MODULE

Post-traumatic Headaches And Available Treatments
Dra. Maria Karina Velez Jimenez Neurologist
Read More
Prof. dr. Gisela Terwindt is consultant neurologist and director of the Leiden Headache Center (LUMC, NL). She is chair of the scientific and headache guideline committee of the Dutch Headache Society and chair of the IHS Clinical Trial Guideline Committee and Female Leadership’s Forum, and participated as a committee member for the Classification of Headache Disorders (ICHD-3). Her research focuses on neurobiological and molecular triggering mechanisms that lead up to migraine attacks to identify treatment targets for prevention of attacks and disease progression. Her group is also studying pathogenesis of monogenic disorders such as Hemiplegic Migraine and Cerebral Hereditary Angiopathies, which serve as models for migraine pathogenesis and help improve insight into pathophysiology of common neurovascular disorders including stroke and vascular dementia. Terwindt is involved in exploring the migraine–stroke relationship, with a special focus on female-specific triggers for migraine and stroke. She has published ≈400 scientific papers, and received a prestigious personal grant from the Dutch Research Council. Terwindt received her MSc in Biology and MD in Medicine at the University of Leiden, Netherlands. Her PhD centred on epidemiology and genetics of migraine, and resulted in the discovery of the first migraine gene. See also www.hoofdpijnonderzoek.nl ; www.whatstudy.nl; www.RVCLS.com
26:36Duration
Start module

3 MODULE

Innovative Non-pharmacological Approaches To Migraine Management
Dawn C Buse, PhD Clinical Professor, Albert Einstein College of Medicine
Read More
Prof. dr. Gisela Terwindt is consultant neurologist and director of the Leiden Headache Center (LUMC, NL). She is chair of the scientific and headache guideline committee of the Dutch Headache Society and chair of the IHS Clinical Trial Guideline Committee and Female Leadership’s Forum, and participated as a committee member for the Classification of Headache Disorders (ICHD-3). Her research focuses on neurobiological and molecular triggering mechanisms that lead up to migraine attacks to identify treatment targets for prevention of attacks and disease progression. Her group is also studying pathogenesis of monogenic disorders such as Hemiplegic Migraine and Cerebral Hereditary Angiopathies, which serve as models for migraine pathogenesis and help improve insight into pathophysiology of common neurovascular disorders including stroke and vascular dementia. Terwindt is involved in exploring the migraine–stroke relationship, with a special focus on female-specific triggers for migraine and stroke. She has published ≈400 scientific papers, and received a prestigious personal grant from the Dutch Research Council. Terwindt received her MSc in Biology and MD in Medicine at the University of Leiden, Netherlands. Her PhD centred on epidemiology and genetics of migraine, and resulted in the discovery of the first migraine gene. See also www.hoofdpijnonderzoek.nl ; www.whatstudy.nl; www.RVCLS.com
25:43Duration
Start module